1 Followers on Owler

Xeno Biosciences

is a bio-pharmaceutical company that develops drugs that mimic the gastric bypass microbiome to treat obesity... Read more
OverviewFundingNews & Insights

Xeno Biosciences

is a bio-pharmaceutical company that develops drugs that mimic the gastric bypass microbiome to treat obesity... Read more
Xeno Biosciences President & CEO: Dennis D. Kim

President & CEO

Dennis D. Kim

CEO Approval Rating

- -/100

2015

Private

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$3.8M

News

Jun 25, 2024
Business Wire
Press Release: Xeno Biosciences : Xeno Biosciences Starts Phase 1b Proof-of-Concept Study in Obesity
Apr 18, 2024
Citybizlist
Xeno Biosciences: Xeno Biosciences Appoints Dennis Kim CEO

Trending Companies